Funding Rounds
SolasCure

SolasCure Series B (2023, $13M)

SolasCure

Treatment for patients with chronic wounds.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $13.36M